Asthenopia Clinical Trial
Official title:
The Role Of Mobile Applications In Therapy Compliance And Efficacy Of Acupressure In Asthenopia
NCT number | NCT06418191 |
Other study ID # | 24-03-0424 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2024 |
Est. completion date | July 2024 |
The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. The main questions it aims to answer are: -Does a mobile application have a role to improve therapy compliance and efficacy of self-guided acupressure in asthenopia? Researchers will compare users of a mobile app to non-users of a mobile app to see if a mobile app works to improve adherence to acupressure therapy in asthenopia Participants will: - Do acupressure 2 times every day for 4 weeks - Filling in the absence link has been after doing acupressure every day - Fill out the link regarding the condition of asthenopia once per week
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | July 2024 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - Using a smartphone with the Android platform. - Work or use digital gadgets for at least 4 hours a day. - Suffering from asthenopia as indicated by a CVS-Q score = 6. - Can be contacted with the WhatsApp application. - Willing to take part in this research until completion and agree to informed consent. Exclusion Criteria: - There are tumors, wounds or skin infections in the eye area. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Indonesia University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Daily Report of Acupressure | Daily acupressure reports are used to monitor participants' therapeutic compliance in performing acupressure every day | 2 times every day for 4 weeks | |
Secondary | Computer Vision Syndrome Questionnaire (CVS-Q) | The Computer Vision Syndrome Questionnaire (CVS-Q) is a tool used to assess symptoms related to prolonged computer use or other digital screens. It typically consists of a series of questions designed to evaluate various discomforts experienced by individuals who spend significant time in front of screens. These questions may inquire about symptoms such as eye strain, headaches, blurred vision, dry eyes, neck or shoulder pain, and general fatigue.
A CVS-Q score = 6 indicates asthenopia |
Monitored once per week for 4 weeks | |
Secondary | Visual Analog Scale (VAS) | VAS is used to assess complaints of asthenopia intensity on a scale of 1-10 | Monitored once per week for 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03585790 -
The Impact of Soft Contact Lens Attributes on Symptoms Associated With Digital Eye Strain in Symptomatic Soft Contact Lens Wearers
|
N/A | |
Terminated |
NCT00585026 -
Randomized Clinical Trial of Bifocal Lenses Versus Computer-specific Progressive Addition Lenses
|
Phase 3 | |
Completed |
NCT00317525 -
Effects of Different Add Powers on the Comfort and Productivity of Computer Users With Fixed or Free Head Movement
|
Phase 3 | |
Recruiting |
NCT05414799 -
Effect of Exercises on Computer Vision Syndrome
|
N/A | |
Completed |
NCT05895500 -
Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia
|
||
Completed |
NCT05089240 -
Objective and Subjective Evaluation of Ophthalmic Lenses With Extra Power
|
N/A | |
Completed |
NCT05201924 -
Bedtime Routines and Children's Health
|
N/A | |
Completed |
NCT02921087 -
Connecting Contact Lenses and Digital Technology
|
N/A | |
Completed |
NCT02641470 -
The Effect of DA9301 on Tablet Computer-Induced Asthenopia
|
N/A | |
Completed |
NCT03544216 -
Accommodative Relief for Uncomfortable Non-Presbyopes
|
N/A | |
Recruiting |
NCT04668118 -
The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
|
Phase 4 |